tirzepatide updates Rybelsus Dosing Update & Single Dose Vial (Zepbound) Big update in pediatric diabetes

The first head-to-head study of the two drugs for obesity, SURMOUNT-5 , was published in The New England Journal of Medicine in May 2025

In addition, the FDA does not intend to take action against an outsourcing facility for use of the bulk drug substance semaglutide to compound, distribute, or dispense a drug product that appeared on FDAs drug shortage list, or for compounding, distributing, or dispensing Semaglutide Injection products that are essentially a copy of an FDAapproved drug product, within 90 days of this decision. Therefore, based on the type of compounding facility there is either a 60- or 90-day window for which enforcement discretion will be exercised

HSA and FSA accounts can be used to cover medication costs, further improving accessibility

Daniel Drucker, a pioneer of GLP-1 research at the University of Toronto whose lab produced the new study

WADA considers three factors when determining whether a substance should be prohibited: its potential to enhance performance, potential health risks, and whether it violates what the agency calls the spirit of sport. Online debate over Williams comeback reflected that uncertainty

after diet and exercise changes and a vertical sleeve gastrectomy